View ICR - OIRA Conclusion



0910-0641 201207-0910-011
Historical Inactive 201207-0910-009
HHS/FDA
Guidance for Industry on Labeling for Products Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Act: Questions and Answers
Extension without change of a currently approved collection   No
Regular
Improperly submitted and continue 10/15/2012
07/27/2012
In accordance with the terms of 5 CFR 1320, this information collection is improperly submitted. Previous terms of clearance require FDA to accurately classify the burden related to third party disclosure. The Agency does not appear to have done so. We also note that the underlying Guidance document should be uploaded as part of the collection.
  Inventory as of this Action Requested Previously Approved
07/31/2012 36 Months From Approved 10/31/2012
100,000 0 100,000
400,000 0 400,000
0 0 0